IL10 and neoplasm: Further confirmation by qPCR and flow cytometry showed that combining B.bif_K57 with the PD-1 inhibitor significantly increased the expression of immune-active cytokines, such as IFN-γ and IL-2, in the tumor, while reducing the expression of immune-suppressive cytokines like TNF-α and IL-10.